The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Running, not enrolling · Phase 3

Conditions studied: HIV Infections

In brief

The purpose of this study was to compare the efficacy, safety, and durability of two different strategies to treat participants with a history of sub-optimal adherence and control of their HIV infection: long-acting (LA) antiretroviral therapy (ART) and all-oral standard of care (SOC).

Key facts

Study ID
NCT03635788
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
456
Starts
2019-03-28
Expected to finish
2026-08-30
Last updated by the study team
2026-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.